MISSION ON IMPROVING PHARMACOVIGILANCE BY REACHING OUT TO THE MEDICAL AND PHARMACEUTICAL COMMUNITY HAS BEEN IMPLEMENTED

During the period of 14-18 January 2019, the last mission of the Activity 2.5 “Improving pharmacovigilance by reaching out to the medical and pharmaceutical community” took place in the Republic of Moldova. The activity is supported within the EU-funded Twinning project “Strengthening of the Medicines and Medical Devices Agency of the Republic of Moldova as regulatory agency in the field of medicines, medical devices and pharmaceutical activity “.

During one week, the Short Term Experts from the Republic of Poland and the Republic of Lithuania shared best practices on pharmacovigilance system in relation of spontaneous reporting system, practical aspects of Periodic Safety Update Report assessment, availability of internationally controlled drugs, import and export of drug and precursor reference standards and Lithuanian regulations concerning travellers under treatment with internationally controlled drugs.

As well, training sessions on adverse drug reactions reporting, periodic safety update report assessment and improvement of knowledge of the latest EU pharmacovigilance assessment, as well as on implementation of drug framework into the national legislation. 

In addition, an analysis of the MMDA pharmacovigilance system in order to develop better methods and procedures to increase awareness levels of the Beneficiary Country individual national collection system was done by the short term experts. 

As a result, the recommendations as to best practice and suggestions for tools and methods to develop were prepared and discussed with the MMDA in order to strengthen pharmacovigilance system of the Republic of Moldova.

The main outcomes of this activity are the Recommendations and criteria for inclusion to the list of medicines for additional monitoring as well as the Key elements to promote adverse drug reactions reporting by public and health care professionals elaborated by the short term experts and delivered to the Beneficiary Country.

 

Noutăţi

08
oct
2019

AMDM invită distribuitori de medicamente şi farmacii la o discuție preliminară privind monitorizarea activă a stocurilor de produse farmaceutice

12
sep
2019

„Raportând reacții adverse puteți reduce suferința și puteți salva vieți!”

09
aug
2019

AMDM a retras din Nomenclatorul de stat ambele forme ale produsului medicamentos STRIM

Development and support SEMSEO

(c) 2015. Agenţia Medicamentului şi Dispozitivelor Medicale